Evidence map›Paper›PMID 42237214›Full record

ArticleBMC genomics2026

Tracing the evolutionary genomics of bla

Jianbo Ye, Yali Zheng, Dakang Hu, Huimin Chen, Yuting Jin, Qiran Ma, Jiayu He, Xinhua Luo

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jianbo Ye *Department of Laboratory Medicine, School of Medicine, Taizhou Key Laboratory of Infection and Tumor Immunology, Taizhou Municipal Hospital (Taizhou University Affiliated Municipal Hospital), Taizhou University, Taizhou, 318000, Zhejiang, China.
Yali Zheng *Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Dakang HuDepartment of Laboratory Medicine, School of Medicine, Taizhou Key Laboratory of Infection and Tumor Immunology, Taizhou Municipal Hospital (Taizhou University Affiliated Municipal Hospital), Taizhou University, Taizhou, 318000, Zhejiang, China.
Huimin ChenDepartment of Laboratory Medicine, School of Medicine, Taizhou Key Laboratory of Infection and Tumor Immunology, Taizhou Municipal Hospital (Taizhou University Affiliated Municipal Hospital), Taizhou University, Taizhou, 318000, Zhejiang, China.
Yuting JinDepartment of Laboratory Medicine, School of Medicine, Taizhou Key Laboratory of Infection and Tumor Immunology, Taizhou Municipal Hospital (Taizhou University Affiliated Municipal Hospital), Taizhou University, Taizhou, 318000, Zhejiang, China.
Qiran MaWenzhou Medical University Renji College, Wenzhou, China.
Jiayu HeTaizhou Jiaojiang District Maternal And Child Health Care Hospital, Taizhou, China.
Xinhua LuoDepartment of Laboratory Medicine, School of Medicine, Taizhou Key Laboratory of Infection and Tumor Immunology, Taizhou Municipal Hospital (Taizhou University Affiliated Municipal Hospital), Taizhou University, Taizhou, 318000, Zhejiang, China. luoxiangnanchang84@163.com.

Funding

the Medical and Health Science and Technology Project of Zhejiang Province 2024KY543the Medical and Health Science and Technology Project of Zhejiang Province 2025KY461the Natural Science Foundation of Zhejiang Province LTGY23H190003
6 · The paper itself

Abstract

backgroundCarbapenem-resistant Salmonella Typhimurium (S. Typhimurium) is occasionally reported, primarily driven by the dissemination of the bla

methodsWe characterized a clinical carbapenem-resistant S. Typhimurium isolate harboring bla

resultsThe bla

conclusionThis study identifies a conjugative and stable IncFII-type plasmid as an important vector for bla

Indexed as

beta-LactamasesEvolution, MolecularGenomicsSalmonella typhimuriumAnti-Bacterial AgentsCarbapenemsChinaConjugation, GeneticGenome, BacterialHumansMicrobial Sensitivity TestsPhylogenyPlasmidsWhole Genome SequencingAnti-Bacterial Agentsbeta-LactamasesCarbapenemsAntimicrobial resistancebla NDMIncFII plasmidPhylogenetic analysisSalmonella Typhimurium

Identifiers

PMID42237214
PMCPMC13449521

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.